Back
45
Also listed as
SNYNF
OTC
Day Range
$45.75
$46.40
52-Week Range
$43.32
$56.93
Volume
1,840,916
50D / 200D Avg
$46.55
/
$48.31
Prev Close
$45.14
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 14.4 | 0.3 |
| P/B | 1.6 | 3.0 |
| ROE % | 10.5 | 3.7 |
| Net Margin % | 16.7 | 3.8 |
| Rev Growth 5Y % | 4.5 | 10.0 |
| D/E | 0.3 | 0.2 |
Analyst Price Target
Hold
$57.02
+23.9%
Low: $48.07
High: $64.00
Forward P/E
10.88
Forward EPS
$4.23
EPS Growth (est.)
+0.0%
Est. Revenue
47.96B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$6.02
$5.74 – $6.53
|
57.87B | 2 |
| FY2029 |
$5.47
$5.21 – $5.93
|
55.73B | 4 |
| FY2028 |
$4.94
$4.71 – $5.36
|
53.32B | 3 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-01-29 | $0.84 | $0.89 | +6.0% |
| 2025-10-24 | $1.60 | $1.70 | +6.3% |
| 2025-07-31 | $0.96 | $0.90 | -6.3% |
| 2025-04-24 | $0.90 | $0.94 | +4.4% |
| 2025-01-30 | $0.71 | $0.70 | -1.4% |
| 2024-10-25 | $1.35 | $1.57 | +16.3% |
| 2024-07-25 | $0.86 | $0.93 | +8.1% |
| 2024-04-25 | $0.94 | $0.97 | +3.2% |
Dividend History
7 yr streakYield
0.05%
Payout Ratio
0.59%
Growth (3Y)
2.67%
Growth (5Y)
4.76%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| May 09, 2025 | Jun 12, 2025 | $2.21 | 4.43% |
| May 09, 2024 | Jun 06, 2024 | $2.04 | 4.18% |
| May 30, 2023 | Jun 23, 2023 | $1.90 | 3.77% |
| May 26, 2022 | Jun 27, 2022 | $0.30 | 3.68% |
| May 04, 2022 | May 31, 2022 | $1.75 | 3.33% |
| May 03, 2021 | May 26, 2021 | $1.93 | 3.75% |
| Apr 30, 2020 | May 26, 2020 | $1.75 | 3.74% |
| May 07, 2019 | May 31, 2019 | $1.74 | 4.23% |
| May 09, 2018 | Jun 04, 2018 | $1.86 | 4.95% |
| May 11, 2017 | Jun 07, 2017 | $1.58 | 3.26% |
| May 05, 2016 | Jun 01, 2016 | $1.63 | 4.17% |
| May 06, 2015 | Jun 02, 2015 | $1.62 | 3.27% |
| May 07, 2014 | Jun 05, 2014 | $1.91 | 3.60% |
| May 06, 2013 | Jun 05, 2013 | $9.31 | 3.51% |
| May 07, 2012 | May 30, 2012 | $8.78 | 4.83% |
| May 11, 2011 | Jun 24, 2011 | $9.11 | 4.78% |
| May 17, 2010 | — | $81.35 | 5.43% |
| Apr 20, 2009 | — | $70.95 | 5.42% |
| May 16, 2008 | — | $75.50 | 4.08% |
| Jun 04, 2007 | — | $57.25 | 2.43% |
Key Takeaways
Revenue grew 4.50% annually over 5 years — modest growth
Earnings grew 40.52% over the past year
ROE of 10.50% — decent returns on equity
Net margin of 16.72% shows strong profitability
Debt/Equity of 0.31 — conservative balance sheet
Generating 8.89B in free cash flow
Growth
Revenue Growth (5Y)
4.50%
Revenue (1Y)5.49%
Earnings (1Y)40.52%
FCF Growth (3Y)1.45%
Quality
Return on Equity
10.50%
ROIC5.11%
Net Margin16.72%
Op. Margin13.58%
Safety
Debt / Equity
0.31
Current Ratio1.09
Interest Coverage11.73
Valuation
P/E Ratio
14.35
Forward P/E10.58
P/B Ratio1.57
EV/EBITDA19.90
Dividend Yield0.05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.49% | Revenue Growth (3Y) | 5.95% |
| Earnings Growth (1Y) | 40.52% | Earnings Growth (3Y) | 20.29% |
| Revenue Growth (5Y) | 4.50% | Earnings Growth (5Y) | 5.85% |
| Profitability | |||
| Revenue (TTM) | 46.72B | Net Income (TTM) | 7.81B |
| ROE | 10.50% | ROA | 6.16% |
| Gross Margin | 72.34% | Operating Margin | 13.58% |
| Net Margin | 16.72% | Free Cash Flow (TTM) | 8.89B |
| ROIC | 5.11% | FCF Growth (3Y) | 1.45% |
| Safety | |||
| Debt / Equity | 0.31 | Current Ratio | 1.09 |
| Interest Coverage | 11.73 | ||
| Dividends | |||
| Dividend Yield | 0.05% | Payout Ratio | 0.59% |
| Dividend Growth (3Y) | 2.67% | Dividend Growth (5Y) | 4.76% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 14.35 | Forward P/E | 10.58 |
| P/B Ratio | 1.57 | P/S Ratio | 2.40 |
| PEG Ratio | -1.66 | Forward PEG | N/A |
| EV/EBITDA | 19.90 | Fwd EV/EBITDA | 9.26 |
| Forward P/S | 2.34 | Fwd Earnings Yield | 9.45% |
| FCF Yield | 7.93% | ||
| Market Cap | 112.10B | Enterprise Value | 126.23B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 46.72B | 44.29B | 41.62B | 40.56B | 39.18B |
| Net Income | 7.81B | 5.56B | 5.40B | 8.37B | 6.22B |
| EPS (Diluted) | 2.03 | 2.19 | 2.15 | 3.18 | 2.49 |
| Gross Profit | 33.79B | 31.08B | 28.99B | 28.68B | 26.92B |
| Operating Income | 6.34B | 7.25B | 6.96B | 10.16B | 8.13B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 126.81B | 132.80B | 126.46B | 126.72B | 120.24B |
| Total Liabilities | 55.10B | 54.94B | 52.11B | 51.57B | 51.21B |
| Shareholders' Equity | 71.38B | 77.51B | 74.04B | 74.78B | 68.68B |
| Total Debt | 21.79B | 17.91B | 18.70B | 21.21B | 22.41B |
| Cash & Equivalents | 7.66B | 7.44B | 8.71B | 12.74B | 10.10B |
| Current Assets | 30.95B | 42.59B | 30.66B | 34.03B | 30.56B |
| Current Liabilities | 28.35B | 29.16B | 24.19B | 23.96B | 21.30B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#515 of 1052
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026